Matthew Brams, MD: Positive Results for CTx-1301 for Adults with ADHD
Researchers are prepared a phase 3 trial testing the treatment in adults with ADHD.
ADHD Coaching During COVID-19
The role of many in psychiatry has changed during the COVID-19 pandemic.
Better Interprofessional Communication Needed in ADHD Coaching
A pair of researchers present plans to improve collaboration with other professionals in ADHD.
David W. Goodman, MD: Silver Linings in ADHD
Dr. David Goodman predicts some patients may improve their organizational skills during the pandemic.
David W. Goodman, MD: Adult ADHD Challenges During COVID-19
Adults with ADHD may face a number of challenges during the ongoing pandemic.
David W. Goodman, MD: APSARD 2021 Bringing Together International ADHD Research
The virtual conference will feature researchers from the US, Germany, Japan, and more.
What Links Asthma to Obesity?
A conversation on how associations between the chronic conditions have become better understood in 10 years.
Peter Lio, MD: Managing and Treating Itch
Peter Lio, MD, discusses conventional therapeutic options for pruritus.
ADM Brett Giroir, MD: Mobilizing a Response to Sickle Cell
ADM Giroir, MD, discusses additional examples of efforts to optimize sickle cell care.
ADM Brett Giroir, MD: The Momentum of Sickle Cell Care
The US Assistant Secretary for Health provides a top-down, government-level perspective on how sickle cell care has advanced in recent years.
Peter Lio, MD: Classifying Itch
Peter Lio, MD, discusses the various underlying causes behind itch.
A. Sidney Barritt, MD: Updating TARGET-NASH
The TARGET-NASH study seeks to shed light on treatment for NASH and NAFLD.
Stefan Bornstein, MD: Adherence Concerns for Diabetic Patients
Amputations have increased 30% among diabetic patients since the pandemic began.
Kausik Ray, MD: Treating Diabetes During COVID-19
There is concern over whether or not patients are adhering to their treatment during the pandemic.
Francesco Giorgino, MD, PhD: Optimizing Diabetes Treatment with SGLT2 Inhibitors
Dr. Giorgino discusses how combining SGLT2 Inhibitors and GLP-1RA could be combined for treating type 2 diabetes.
Stefan Bornstein, MD: Diabetic Patients During COVID-19
Diabetic patients are more susceptible to severe COVID-19 outcomes.
Kausik Ray, MD: Promising New Cholesterol Lowering Agents
Dr. Kausik Ray presents new data on inclisiran and bempedoic acid as cholesterol lowering medications.
Lisa Swanson, MD: New Treatments for Pediatric Atopic Dermatitis
A pediatric dermatologist discusses dupilumab for pediatric atopic dermatitis in addition to promising new therapies.
Thoughts on AAO 2020: Uveitis Subspecialty Day
A uveitis specialist breaks down what occurs during the uveitis-dedicated event and comments on its importance.
Ehsan Rahimy, MD: The Importance of Continued Geographic Atrophy Screening
A new IRIS registry analysis reports that many patients with geographic atrophy do not continue follow-up after initial visit or consultation.
Lisa Swanson, MD: Pediatric Psoriasis, Impact and Treatment Strategies
A pediatric dermatologist discusses her experience managing and treating psoriasis in children.
Girish Hiremath, MD, MPH: Accurately Tracking Pediatric Compliance to EoE Therapies
Girish Hiremath, MD, MPH, discusses a need to more accurately and objectively assess pediatric compliance to eosinophilic esophagitis therapies.
CDC Guidelines and Detecting C. Difficile Infection
The CDC has standardized guidelines to help diagnose diarrhea, a potential indicator of c. difficile infection.
Outcomes of Endoscopic Bariatric Therapies in Diabetic Patients
Benjamin Noor, MD, discusses a recent study from ACG that demonstrated that EBTs are associated with improved parameters for weight loss and diabetes.
Girish Hiremath, MD, MPH: Pediatric Compliance to EoE Therapies
An expert discusses a study assessing the effects of low compliance to eosinophilic esophagitis therapies among pediatric patients.
Brad Glick, DO, FAAD: Trends and Advancements in Dermatology
Brad Glick gives an overview of new and exciting trends in the field of dermatology.
Brad Glick, DO, FAAD: Dermatology, COVID-19, Skin Pigmentation and Race
Brad Glick, DO, FAAD, previews a few of the topics that will be discussed on Derm Discussions, HCPLive's new expert-led skin health podcast series.
Brad Glick, DO, FAAD: Introduction to Derm Discussions
The host of HCPLive's new derm podcast series discusses what to expect as well as the importance of multimedia medical news.
Lakiea Wright, MD: Managing Symptoms of Allergic Asthma
An expert offers 5 tips to physicians and patients on best practices for managing symptoms related to allergic asthma.
Paul Christo, MD: Addressing Opioid Addiction during the COVID-19 Pandemic
Paul Christo, MD, discusses opioid addiction during the pandemic, the role of the clinician, and offers a hopeful outlook for the future.
